197 related articles for article (PubMed ID: 7949653)
1. Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
King MJ; Chan A; Roe R; Warren BF; Dell A; Morris HR; Bartolo DC; Durdey P; Corfield AP
Glycobiology; 1994 Jun; 4(3):267-79. PubMed ID: 7949653
[TBL] [Abstract][Full Text] [Related]
2. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.
Thurnher M; Clausen H; Fierz W; Lanzavecchia A; Berger EG
Eur J Immunol; 1992 Jul; 22(7):1835-42. PubMed ID: 1378020
[TBL] [Abstract][Full Text] [Related]
3. O-linked oligosaccharides of glycophorins A and B in erythrocytes of two individuals with the Tn polyagglutinability syndrome.
Blumenfeld OO; Lalezari P; Khorshidi M; Puglia K; Fukuda M
Blood; 1992 Nov; 80(9):2388-95. PubMed ID: 1421410
[TBL] [Abstract][Full Text] [Related]
4. Lectinochemical studies on the glyco-recognition factors of a Tn (GalNAcalpha1-->Ser/Thr) specific lectin isolated from the seeds of Salvia sclarea.
Wu AM
J Biomed Sci; 2005; 12(1):167-84. PubMed ID: 15864748
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic basis for sialyl-Tn expression in human colon cancer cells.
Brockhausen I; Yang J; Dickinson N; Ogata S; Itzkowitz SH
Glycoconj J; 1998 Jun; 15(6):595-603. PubMed ID: 9881766
[TBL] [Abstract][Full Text] [Related]
6. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
8. Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma.
Zhuang D; Yousefi S; Dennis JW
Cancer Biochem Biophys; 1991 Nov; 12(3):185-98. PubMed ID: 1844911
[TBL] [Abstract][Full Text] [Related]
9. Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.
Hiraiwa N; Tsuyuoka K; Li YT; Tanaka M; Seno T; Okubo Y; Fukuda Y; Imura H; Kannagi R
Cancer Res; 1990 Sep; 50(17):5497-503. PubMed ID: 2167157
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of cancer-associated carbohydrate antigens, Tn and sialyl Tn.
Nakada H; Inoue M; Tanaka N; Yamashina I
Glycoconj J; 1994 Jun; 11(3):262-5. PubMed ID: 7841802
[TBL] [Abstract][Full Text] [Related]
11. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical studies on the differential binding properties of two monoclonal antibodies reacting with Tn red cells.
King MJ; Parsons SF; Wu AM; Jones N
Transfusion; 1991 Feb; 31(2):142-9. PubMed ID: 1847560
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of sialosyl-Tn (NeuAc alpha 2----6GalNAc alpha 1----O-Ser/Thr) and Tn (GalNAc alpha 1----O-Ser/Thr) blood group antigens on Tn erythrocytes.
Kjeldsen T; Hakomori S; Springer GF; Desai P; Harris T; Clausen H
Vox Sang; 1989; 57(1):81-7. PubMed ID: 2800471
[TBL] [Abstract][Full Text] [Related]
14. Alterations of O-glycan biosynthesis in human colon cancer tissues.
Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I
Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850
[TBL] [Abstract][Full Text] [Related]
15. Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase.
Kono M; Tsuda T; Ogata S; Takashima S; Liu H; Hamamoto T; Itzkowitz SH; Nishimura S; Tsuji S
Biochem Biophys Res Commun; 2000 May; 272(1):94-7. PubMed ID: 10872809
[TBL] [Abstract][Full Text] [Related]
16. Tk, a new colon tumor-associated antigen resulting from altered O-glycosylation.
Meichenin M; Rocher J; Galanina O; Bovin N; Nifantev N; Sherman A; Cassagnau E; Heymann MF; Bara J; Fraser RH; Le Pendu J
Cancer Res; 2000 Oct; 60(19):5499-507. PubMed ID: 11034094
[TBL] [Abstract][Full Text] [Related]
17. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.
Vavasseur F; Dole K; Yang J; Matta KL; Myerscough N; Corfield A; Paraskeva C; Brockhausen I
Eur J Biochem; 1994 Jun; 222(2):415-24. PubMed ID: 8020479
[TBL] [Abstract][Full Text] [Related]
18. Tn epitopes, immunoreactive with ordinary anti-Tn antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom.
Springer GF; Desai PR
Mol Immunol; 1985 Nov; 22(11):1303-10. PubMed ID: 2417112
[TBL] [Abstract][Full Text] [Related]
19. O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas.
Orntoft TF; Harving N; Langkilde NC
Int J Cancer; 1990 Apr; 45(4):666-72. PubMed ID: 2323843
[TBL] [Abstract][Full Text] [Related]
20. Polyvalent GalNAcalpha1-->Ser/Thr (Tn) and Galbeta1-->3GalNAcalpha1-->Ser/Thr (T alpha) as the most potent recognition factors involved in Maclura pomifera agglutinin-glycan interactions.
Wu AM
J Biomed Sci; 2005; 12(1):135-52. PubMed ID: 15864746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
